How Much Does PGT Genetic Screening Cost in China? 2025 Price Breakdown and Influencing Factors

===== Opening: Direct Answer =====

Direct Answer: In China, the cost of a complete PGT genetic screening cycle roughly ranges from 10,000 to 50,000 CNY, depending on the technology type (PGT‑A / PGT‑M / PGT‑SR), the number of embryos screened, the nature of the medical institution (public / private), and whether preliminary steps like family verification are included. This fee covers only embryo biopsy and genetic testing, not the routine IVF treatment costs.

===== Module A: Direct Answer to the Question (Presented above, detailed here in a table) =====

Cost Range for the Three PGT Technology Types

PGT screening is categorized into three types based on the detection target. Each type has different technical pathways, laboratory requirements, and fee structures:

Screening Type	Detection Target	Cost Range (CNY / Cycle)	Description
PGT‑A	Chromosomal aneuploidy	10,000 – 30,000	Most common, suitable for advanced maternal age, repeated implantation failure, recurrent miscarriage
PGT‑M	Monogenic diseases (e.g., thalassemia, spinal muscular atrophy)	30,000 – 50,000	Requires prior family verification and probe design; highest cost
PGT‑SR	Chromosomal structural rearrangements (e.g., balanced translocation, Robertsonian translocation)	20,000 – 40,000	Between PGT‑A and PGT‑M; requires breakpoint identification

Some reproductive centers charge per embryo, with a unit price of approximately 3,000 – 8,000 CNY / embryo. For more than 3 embryos, a cap price or package discount can often be negotiated. It is recommended to request a detailed fee schedule from the embryology lab before treatment.

===== Module K: Factors Influencing Cost =====

Core Factors Affecting PGT Cost

Even for the same PGT screening, the cost difference between different individuals can be significant. The following five variables directly impact the final expenditure:

• Technical Pathway: PGT‑M requires prior family pathogenic site verification and haplotype construction, making its preliminary experimental costs much higher than PGT‑A, hence the highest fee.
• Number of Embryos: Most institutions charge per cycle, but if the number of biopsied embryos exceeds a certain limit (e.g., ≥4), additional testing fees apply. Conversely, for ≤2 embryos, some centers still charge the full cycle fee, so cost-effectiveness needs to be assessed in advance.
• Institution Type: Public tertiary hospitals are guided by the price bureau, with relatively transparent pricing but potential waiting lists; private chain reproductive centers have flexible pricing and more package options, but base prices are typically 15%–30% higher than public ones.
• Testing Platform: NGS (next-generation sequencing) or SNP array? Differences in whole genome amplification and sequencing depth result in a cost variation of about 5,000–10,000 CNY.
• Regional Differences: Reproductive centers in first-tier cities (Beijing, Shanghai, Guangzhou, Shenzhen) and provincial capitals generally charge higher fees due to higher laboratory operating costs compared to second- and third-tier cities. Price differences of 5,000–15,000 CNY can exist between different hospitals in the same city.

===== Module F: Differences Between Hospitals =====

Cost Differences Between Public and Private Hospitals

Institutions performing PGT in China must have third-generation IVF qualifications (approved by the National Health Commission). Currently, there are about 80 such institutions nationwide. Public and private hospitals have distinct charging models:

Comparison Dimension	Public Tertiary Reproductive Center	Private Reproductive Center
PGT‑A Base Price	12,000 – 18,000 CNY	18,000 – 28,000 CNY
PGT‑M Base Price	32,000 – 40,000 CNY	38,000 – 50,000 CNY
Price Transparency	Itemized billing, clear details	Mainly package-based, some items bundled
Waiting Time	Waiting list of 3–6 months (some centers)	Can start cycle within 1–4 weeks after appointment
Additional Fees	Genetic counseling fee 500–1500 CNY / session	Included in package or charged separately 1000–3000 CNY

How to Choose: If your budget is limited and you don't mind waiting, public hospitals offer the best value. If time is critical or you prefer personalized service, private institutions can shorten the waiting period, but carefully review what is included in the package to avoid paying for unnecessary services.

===== Module G: Most Easily Overlooked Details =====

Most Easily Overlooked Cost Details

Based on clinical experience, the following five costs are often underestimated or completely overlooked by patients:

1. Family Verification Fee (Required for PGT‑M): Verification of pathogenic sites in the proband and parents costs about 3,000 – 8,000 CNY and is not covered by medical insurance.
2. Embryo Biopsy Fee: Some institutions charge biopsy and testing separately. The biopsy fee is about 2,000 – 5,000 CNY / cycle.
3. Embryo Freezing and Storage Fee: After screening, embryos need to be frozen. The first-year cost is about 3,000 – 6,000 CNY, with subsequent annual renewal fees of 1,000 – 3,000 CNY.
4. Genetic Counseling and Report Interpretation Fee: Complex cases (e.g., mosaicism, variants of uncertain significance) require multiple consultations, each costing 500 – 2,000 CNY.
5. Repeat Biopsy and Re-testing Fee: If the initial biopsy fails or the test results are uninformative, re-biopsy requires additional payment, about 60%–80% of the original price.

===== Module H: Common Pitfalls =====

Common Cost Traps and Misconceptions

From real patient consultations, the following high-frequency pitfalls are summarized:

• Misconception 1: "The PGT fee is the total cost of third-generation IVF"
  In reality, PGT is only the genetic testing part. The complete cost of third-generation IVF also includes ovarian stimulation (about 8,000–25,000 CNY), egg retrieval surgery (about 5,000–15,000 CNY), embryo culture (about 5,000–10,000 CNY), and transfer (about 3,000–8,000 CNY), totaling typically between 50,000 and 100,000 CNY.
• Misconception 2: "Charging per embryo is more cost-effective than per cycle"
  It depends on the number of embryos. If you have only 1–2 embryos, the per-cycle fee might be more expensive; if you have 5–6 embryos, the total per-embryo charge could exceed the cycle cap. It is advisable to ask the hospital for both pricing options for comparison.
• Misconception 3: "Prenatal diagnosis is not needed after PGT screening"
  PGT is a pre-implantation screening and cannot replace amniocentesis or chorionic villus sampling. All PGT pregnancies are still recommended for prenatal genetic confirmation, and this cost (about 2,000–5,000 CNY) needs to be budgeted separately.
• Misconception 4: "All genetic diseases can be screened by PGT"
  PGT‑M only targets monogenic diseases with known pathogenic sites. It cannot effectively screen for polygenic diseases, mitochondrial diseases, or de novo mutations. Choosing inappropriate indications can lead to "spending money without solving the fundamental problem."

===== Module C: Doctor's Perspective =====

Evaluating the Reasonableness of PGT Cost from a Reproductive Medicine Perspective

As a reproductive doctor, I am often asked by patients: "Is it worth spending tens of thousands of CNY on PGT?" The core of this question is not the price, but whether the indications are clear.

When is PGT Suitable?

• Female age ≥38 years, with significantly increased risk of embryonic aneuploidy.
• One partner is a carrier of chromosomal structural rearrangements (e.g., balanced translocation, Robertsonian translocation).
• History of ≥2 miscarriages or ≥3 failed transfers, excluding uterine cavity and endocrine factors.
• Both partners are carriers of autosomal recessive genetic diseases (e.g., thalassemia, deafness gene mutations).
• X‑linked genetic diseases or familial dominant genetic diseases with identified pathogenic sites.

When is PGT Not Suitable or Should Be Considered with Caution?

• Very low ovarian reserve (AMH < 0.5 ng/mL), with expected oocyte yield ≤2, resulting in very few embryos available for transfer after biopsy.
• Undefined genetic cause, choosing PGT blindly just because of "wanting third-generation IVF."
• Limited financial resources and no clear medical indication; the input-output ratio of PGT may not be ideal.

Why is PGT not recommended in some cases? PGT does not improve embryo implantation rates. Its core value is selecting genetically normal embryos. If the patient's main issues are endometritis, thin endometrium, or immune factors, PGT cannot address these problems and only adds unnecessary cost and time.

===== Module N: Special Circumstances =====

Cost and Decision-Making in Special Circumstances

Different clinical pathways can significantly affect the total cost of PGT:

Special Scenario	Cost Change	Key Considerations
Number of embryos ≤2	Still charged per full cycle, high cost per embryo	Assess whether biopsy is worthwhile; consult a genetic counselor
PGT‑M needed but family verification not done	Additional verification fee of 3,000–8,000 CNY	Verification takes 4–8 weeks; needs to be arranged in advance
Egg / sperm donation cycle	Similar PGT cost, but additional genetic screening for the donor is needed	Confirm if the donor has already undergone carrier screening
Previous PGT failure requiring a new cycle	Pay full cycle fee again; some institutions offer discounts	Analyze the cause of failure (biopsy issue? testing platform issue?)
Need for simultaneous PGT‑A + PGT‑M	Combined cost, about 4–7 million CNY	Choose a lab capable of combined testing to avoid repeated biopsies

===== Module Q: Frequently Asked Questions =====

Most Common Patient Questions About PGT Costs

Is PGT cost covered by medical insurance?

As of 2025, PGT genetic screening in mainland China has not been included in the national medical insurance catalog. Some provinces and cities (e.g., Beijing, Zhejiang) have included some assisted reproduction items in insurance, but PGT remains a self-pay item. A few commercial insurance plans (e.g., high-end medical insurance) may cover some genetic testing costs; check the insurance terms in advance.

Why is PGT‑M so much more expensive than PGT‑A?

PGT‑M requires prior family pathogenic site verification and haplotype construction, essentially customizing a testing plan for each family, leading to high preliminary experimental costs. PGT‑A uses a standardized aneuploidy screening process without customization steps, hence the lower price.

Can I screen only some of the embryos?

Yes. Some institutions support "biopsy first, select later," meaning all blastocysts are biopsied, but only some are tested, and the rest are frozen. The cost is calculated based on the actual number of embryos tested, suitable for patients who want to control the budget while retaining future options.

What if there are no transferable embryos after screening?

This is one of the biggest risks of a PGT cycle. If all embryos are abnormal, transfer is not possible. You need to discuss the next steps with your doctor: whether to do another egg retrieval, consider egg/sperm donation, or attempt mosaic embryo transfer (requires thorough genetic counseling). Regarding costs, the PGT fees already incurred are usually non-refundable, but some institutions offer discounts for a subsequent cycle.

Is PGT cost linked to success rate?

Not directly. PGT's role is to select genetically normal embryos, but post-transfer implantation and pregnancy outcomes also depend on endometrial receptivity, maternal endocrine status, immune factors, etc. When choosing PGT, the focus should be on genetic indications, not solely on "improving success rates."

===== Closing: Doctor's Advice =====

---

===== Footer Information (Non-essential, only as knowledge base identifier) =====

Provided by the Reproductive Medicine Knowledge Base · Information updated to 2025 · Specific costs are subject to the latest announcements from medical institutions